Protopapas Anna (CIK 0001347582)

Latest company ownership

Shares held
55,000
Last filed at
Jun 12, 2024
Confidence Score
49.9
2025Q4
Confidence Score History
2021Q1 2025Q4
NUVL - Nuvalent, Inc.
Role: Director
Shares held
4,147
Last filed at
Jun 20, 2025
Confidence Score
50.0
2025Q4
Confidence Score History
2023Q4 2025Q4

Recent buy/sell transactions

Exec date Filing date Company Role Signal Confidence Shares % of shares Under plan? Amount (USD)
Jan 15, 2025 Jan 17, 2025 Mersana Therapeutics, Inc. Director Sell 50.0 -8,637 -1.77% ✓ $5K
Jan 14, 2025 Jan 16, 2025 Mersana Therapeutics, Inc. Director Sell 50.0 -6,191 -1.31% ✓ $3.9K
Jan 13, 2025 Jan 15, 2025 Mersana Therapeutics, Inc. Director Sell 46.3 -11,534 -2.46% ✓ $7.6K
Jan 13, 2024 Jan 17, 2024 Mersana Therapeutics, Inc. Director Sell 32.5 -29,399 -6.29% ✓ $79.7K
Dec 18, 2023 Dec 20, 2023 Nuvalent, Inc. Director Sell 20.0 -5,000 -100.00% ✗ $378.4K
May 20, 2022 Jan 18, 2023 Mersana Therapeutics, Inc. CEO Sell 42.5 -17,346 -5.48% ✗ $99.6K
Jul 15, 2021 Jul 19, 2021 Mersana Therapeutics, Inc. CEO Sell 40.0 -41,944 -12.91% ✗ $513.2K
Jan 15, 2021 Jan 20, 2021 Mersana Therapeutics, Inc. CEO Sell 42.5 -5,198 -2.26% ✗ $109.6K